InMed Pharmaceuticals Inc(INM)_个股概要_股票价格_最新资讯_行情走势_历史数据

InMed Pharmaceuticals Inc(INM)

盘后0.24040.00-0.66%17:34 EDT

0.2420-0.0219-8.30%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
InMed Pharmaceuticals Inc
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.inmedpharma.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
InMed Pharmaceuticals Inc.根据不列颠哥伦比亚省商业公司法，于1981年5月19日在不列颠哥伦比亚省注册成立。该公司是一家临床阶段的制药公司，致力于开发针对医疗需求未得到满足的疾病的处方药，并开发专利制造技术。该公司正在开发一种基于生物合成的集成制造方法，称为IntegraSynTM，用于合成药物级大麻素以及多种候选产品。该公司致力于为可能受益于大麻素类药物的患者提供新的治疗替代品。
- 04-18
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 04-16
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 04-05
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 03-20
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 02-14
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 02-14
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 02-14
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 02-09
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 01-20
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 01-17
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2023-12-22
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 2023-12-21
  [修订]年度报告
  Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
  Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
- 2023-12-20
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2023-11-30
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2023-11-15
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report